Summary:
The phase IV clinical study analyzes what interactions people have when they take Thiothixene and Olanzapine. It is created by eHealthMe based on reports of 10 people who take the same drugs from the FDA, and is updated regularly.
Thiothixene and Olanzapine can behave differently in people of different gender and age, or after taking with other drugs. But how do you know? With medical big data and AI/ML algorithms, eHealthMe runs millions of phase IV clinical trials to monitor drug outcomes in the real world. Our original studies have been referenced on 700+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Check your drugs now, it's personalized to your gender and age.
On Aug, 01, 2024
10 people who take Thiothixene and Olanzapine together, and have interactions are studied.
What is Thiothixene?
Thiothixene has active ingredients of thiothixene. eHealthMe is studying from 321 Thiothixene users for its effectiveness, alternative drugs and more.
What is Olanzapine?
Olanzapine has active ingredients of olanzapine. It is often used in bipolar disorder. eHealthMe is studying from 69,228 Olanzapine users for its effectiveness, alternative drugs and more.
Number of Thiothixene and Olanzapine reports submitted per year:
Common Thiothixene and Olanzapine drug interactions by gender *:
female:
- Blood glucose decreased
- Diabetes mellitus
- Diabetic neuropathy
- Dyskinesia
- Injury
- Obesity
- Sciatic nerve neuropathy
- Tardive dyskinesia
- Type 2 diabetes mellitus
male:
- Hypercholesterolaemia
- Hyperglycaemia
- Disorientation
- Drug hypersensitivity
- Erythrocyte sedimentation rate increased
- Fall
- Fear
- Hallucination, auditory
- Hypertension
- Hypotension
Common Thiothixene and Olanzapine drug interactions by age *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Hypercholesterolaemia
- Hyperglycaemia
- Drug ineffective
- Self injurious behaviour
- Fear
- Hallucination, auditory
- Psychotic disorder
- Self-injurious ideation
40-49:
- Diabetic neuropathy
- Disorientation
- Drug hypersensitivity
- Erythrocyte sedimentation rate increased
- Hypertension
- Injury
- Malaise
- Myalgia
- Obesity
- Pyrexia
50-59:
- Abnormal behaviour
- Fall
60+:
n/a
Common conditions people have *:
- Hallucination, Auditory (perceiving sounds without auditory stimulus): 2 people, 20.00%
- Schizophrenia, Paranoid Type (delusions and auditory hallucinations but relatively normal intellectual functioning and expression of affect): 1 person, 10.00%
- Impaired Gastric Emptying: 1 person, 10.00%
* Approximation only. Some reports may have incomplete information.
Do you take Thiothixene and Olanzapine?
Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
- Og?odek E, Szota A, Araszkiewicz A, "Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment", Aust NZJ Psychiatry, 2013 Oct .
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
- Thiothixene (321 reports)
- Olanzapine (69,228 reports)
Browse all drug interactions of Thiothixene and Olanzapine:
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all interactions between Thiothixene and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all interactions between Olanzapine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on thiothixene and olanzapine (the active ingredients of Thiothixene and Olanzapine, respectively), and Thiothixene and Olanzapine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Gout and Cardiac Murmur - now
- Levothyroxine Sodium and Fistula Discharge - now
- Glyburide And Metformin Hydrochloride and Starlix drug interaction - a second ago
- Acarbose and Decadron drug interaction - 7 seconds ago
- Nystatin and Blood Glucose Decreased - 9 seconds ago
- Enbrel and White Blood Cells Urine Positive - 10 seconds ago
- Epzicom and Diabetes Mellitus Inadequate Control - 13 seconds ago
- Propacet 100 and Haematocrit Decreased - 17 seconds ago
- Metformin and Akynzeo drug interaction - 18 seconds ago
- Rebetol and Pulmonary Oedema Aggravated - 22 seconds ago
